Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
62 NC counties and 1 VA county are under alert, including Northampton County.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Omeros Corp
(NQ:
OMER
)
5.060
+0.040 (+0.80%)
Streaming Delayed Price
Updated: 9:58 AM EDT, Aug 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Omeros Corp
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 30, 2022
Gainers Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million.
Via
Benzinga
Omeros's Return On Capital Employed Insights
March 07, 2022
According to Benzinga Pro, during Q4, Omeros (NASDAQ:OMER) earned $280.62 million, a 1336.05% increase from the preceding quarter. Omeros also posted a total of $30.84 million in...
Via
Benzinga
Omeros: Q4 Earnings Insights
March 01, 2022
Omeros (NASDAQ:OMER) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Omeros missed...
Via
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...
Via
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 18, 2022
Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...
Via
Benzinga
Omeros Submits Response To FDA Regarding Narsoplimab Application In HSCT-TMA
January 20, 2022
Omeros Corporation (NASDAQ: OMER) has submitted to the FDA its response to Complete Response Letter for narsoplimab in hematopoietic stem cell transplant-associated...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 09, 2021
Gainers Applied DNA Sciences (NASDAQ:APDN...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 03, 2021
Gainers Lixte Biotech Holdings (NASDAQ:LIXT
Via
Benzinga
Omeros Offloads Cataract Med Omidria To Rayner Surgical In Deal Valued Over $1B
December 02, 2021
Omeros Corporation (NASDAQ: OMER) has agreed to sell Omidria to Rayner Surgical Group Limited for an upfront payment of $125 million with an additional $200...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 02, 2021
Gainers Omeros (NASDAQ:OMER) stock increased by 15.68% to $7.89 during Thursday's pre-market session. The market value of their outstanding shares is at $493.4 million...
Via
Benzinga
76 Biggest Movers From Yesterday
November 11, 2021
Gainers Expensify, Inc. (NASDAQ: EXFY) jumped 52.1% to settle at $41.06 on Wednesday after the company priced its IPO at $27 per share. RenovoRx, Inc. (NASDAQ: RNXT) shares...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Omeros: Q3 Earnings Insights
November 09, 2021
Omeros (NASDAQ:OMER) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Omeros...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
Earnings Outlook For Omeros
November 08, 2021
Omeros (NASDAQ:OMER) is set to give its latest quarterly earnings report on Tuesday, 2021-11-09. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Omeros' Narsoplimab Shows Improved, Stabilized Renal Function At Three Years
November 05, 2021
Omeros Corporation (NASDAQ: OMER) announced long-term follow-up (35 months) results from the Phase 2 trial of its MASP-2 inhibitor narsoplimab in patients with IgA...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates
November 02, 2021
The loaded Prescription Drug User Fee Act (PDUFA) calendar for October produced mixed outcomes. PDUFA dates are key binary events for biotech stocks that can move the needle in a...
Via
Benzinga
3 Beaten-Down Biotech Stocks -- Can They Recover?
October 31, 2021
Each for reasons of their own, Atea Pharmaceuticals, Omeros, and Novavax have had a very tough time this year.
Via
The Motley Fool
10 Biggest Price Target Changes For Tuesday
October 19, 2021
Goldman Sachs boosted Walmart Inc. (NYSE:WMT) price...
Via
Benzinga
46 Biggest Movers From Yesterday
October 19, 2021
Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial...
Via
Benzinga
Omeros Stock Falls As FDA Asks For More Clinical Narsoplimab Data In HSCT-TMA
October 18, 2021
The FDA issued a Complete Response Letter (CRL) related to Omeros Corporation's (NASDAQ: OMER) marketing application for narsoplimab for hematopoietic...
Via
Benzinga
Exposures
Product Safety
Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher
October 18, 2021
Toward the end of trading Monday, the Dow traded down 0.20% to 35,223.86 while the NASDAQ rose 0.68% to 14,998.54. The S&P also rose, gaining 0.19% to 4,480.05. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benchmarks Pare Losses on Upbeat Earnings Outlook
October 18, 2021
The major benchmarks are paring earlier losses at midday, fresh off of their best week in months as earnings season kicks off.
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
October 18, 2021
Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 EST, Progenity's stock is trading at a volume of...
Via
Benzinga
Mid-Day Market Update: Nasdaq Rises 50 Points; Revance Therapeutics Shares Plummet
October 18, 2021
Midway through trading Monday, the Dow traded down 0.05% to 35,275.96 while the NASDAQ rose 0.34% to 14,948.46. The S&P also rose, gaining 0.19% to 4,479.71. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Here's Why Omeros Is Sinking Further Today
October 18, 2021
Bad news the company received today from the FDA surprised investors more than it probably should have.
Via
The Motley Fool
Exposures
Product Safety
34 Stocks Moving In Monday's Mid-Day Session
October 18, 2021
Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare....
Via
Benzinga
Mid-Morning Market Update: Markets Mostly Lower; Albertsons Tops Q2 Estimates
October 18, 2021
Following the market opening Monday, the Dow traded down 0.32% to 35,182.99 while the NASDAQ rose 0.12% to 14,915.84. The S&P also fell, dropping 0.06% to 4,468.81. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 18, 2021
Gainers Valneva (NASDAQ:VALN) stock increased by 35.65% to $38.05 during Monday's pre-market session. The market value of their outstanding shares is at $1.8 billion....
Via
Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.